摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-ethynylphenyl)-1H-imidazole | 1123827-71-3

中文名称
——
中文别名
——
英文名称
1-(4-ethynylphenyl)-1H-imidazole
英文别名
1-(4-ethynylphenyl)imidazole
1-(4-ethynylphenyl)-1H-imidazole化学式
CAS
1123827-71-3
化学式
C11H8N2
mdl
——
分子量
168.198
InChiKey
JGOYNXHKBLLFEQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    304.2±25.0 °C(Predicted)
  • 密度:
    1.00±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    17.8
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(4-ethynylphenyl)-1H-imidazoleN-溴代丁二酰亚胺(NBS)2,4,5,6-四(9H-咔唑-9-基)异酞腈1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下, 以 N,N-二甲基甲酰胺乙腈 为溶剂, 反应 24.0h, 生成 1-(4-(3,3-dimethylbut-1-yn-1-yl)phenyl)-1H-imidazole
    参考文献:
    名称:
    可见光介导的无应变酮的脱酰化炔基化
    摘要:
    首次报道了在蓝光照射下由有机光催化剂催化的未应变酮的解构炔基化。具有多达 63 个实例的广泛底物范围、出色的官能团耐受性和克级反应证明了这种新型炔基化方法的实用性。三氟苯乙酮的二氢喹唑啉酮衍生物在与各种炔基溴化物的三氟甲基化反应中表现良好,已被证明具有作为新型三氟甲基化试剂的潜力。
    DOI:
    10.1021/acs.orglett.3c00145
  • 作为产物:
    参考文献:
    名称:
    Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 Diabetes
    摘要:
    GPR142 has been identified as a potential glucose-stimulated insulin secretion (GSIS) target for the treatment of type 2 diabetes mellitus (T2DM). A class of triazole GPR142 agonists was discovered through a high throughput screen. The lead compound 4 suffered from poor metabolic stability and poor solubility. Lead optimization strategies to improve potency, efficacy, metabolic stability, and solubility are described. This optimization led to compound 20e, which showed significant reduction of glucose excursion in wild-type but not in GPR142 deficient mice in an oral glucose tolerance test (oGTT) study. These studies provide strong evidence that reduction of glucose excursion through treatment with 20e is GPR142-mediated, and GPR142 agonists could be used as a potential treatment for type 2 diabetes.
    DOI:
    10.1021/acsmedchemlett.6b00314
点击查看最新优质反应信息

文献信息

  • Synthesis of unsymmetrical imidazolium salts by direct quaternization of N-substituted imidazoles using arylboronic acids
    作者:Shiqing Li、Fan Yang、Taiyong Lv、Jingbo Lan、Ge Gao、Jingsong You
    DOI:10.1039/c4cc00474d
    日期:——
    Imidazolium salts were conveniently prepared by direct aryl quaternization using arylboronic acids. This process features the tolerance of a broad range of functional groups and excellent chemoselectivity, and is especially effective for the synthesis of unsymmetrical imidazolium salts.
    咪唑盐可通过直接芳基季化反应方便地制备,该反应采用芳基硼酸作为原料。该方法具有对多种官能团的耐受性和优异的化学选择性,尤其适用于非对称咪唑盐的合成。
  • Copper-Catalyzed Direct Aryl Quaternization of <i>N</i>-Substituted Imidazoles to Form Imidazolium Salts
    作者:Taiyong Lv、Zhi Wang、Jingsong You、Jingbo Lan、Ge Gao
    DOI:10.1021/jo400527r
    日期:2013.6.7
    Diaryliodonium salts are employed to directly quaternize N-substituted imidazoles by using a copper catalyst to construct aryl imidazolium salts in moderate to excellent yields. This transformation is tolerant to a broad range of functional groups and provides a straightforward, efficient, and versatile route to synthesize aryl imidazolium as well as triazolium salts, especially the unsymmetric version.
  • Highly Functional Group Tolerance in Copper-Catalyzed <i>N</i>-Arylation of Nitrogen-Containing Heterocycles under Mild Conditions
    作者:Liangbo Zhu、Gaocan Li、Liang Luo、Peng Guo、Jingbo Lan、Jingsong You
    DOI:10.1021/jo802669b
    日期:2009.3.6
    A copper-catalyzed process has been developed for the N-arylation reaction under very mild conditions in the absence of additional ligand. This protocol could not only tolerate an array of thermally sensitive functional groups, but also achieve high chemoselectivity.
查看更多